Valeriu Djugostran

Valeriu Djugostran

Auto-generated profile, based on publicly available information

Valeriu Djugostran

IMSP Institutul Ftiziopneumologie “Chiril Draganiuc

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
VAVasile Antipa
Vasile Antipa
VDValerii Djugostran
Valerii Djugostran
OCOlga Calenda
Olga Calenda
The data of 165 patients were analyzed, of which 121 with pulmonary tuberculosis, new cases, who were treated according to the modified DOTS schemes with retrosternal instillation of the 10%-5ml isoniazid solution and 44 patients with pulmonary tuberculosis associated with human immunodeficiency virus, who received standard antituberculosis and antiretroviral treatment. The patients were assessed the reactions of general nonspecific adaptation, the reactivity levels of the organization and the sum of the score accumulated by the patient according to the method of L.H.Garcavi and coaut., 1979. It was found that in the quotas of patients from both groups up to treatment prevailed low levels of reactivity of the organism, which after the intensive phase DOTS (and corresponding – antiretroviral treatment) in patients only with pulmonary tuberculosis or more maintained at 50%, and in the group and with HIV Association low levels remained the same. Pathological adaptation reactions at that time in the first group persisted in every third patient, while in the other group they remained without changes. These data are useful in assessing the risk of activation of the process, the prognosis of further evolution of the disease and the correction of curative measures.

1 January 2025 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Closed access
VAVasile Antipa
Vasile Antipa
LPLarisa Procopisin
Larisa Procopisin
VDValeriu Djugostran
Valeriu Djugostran
The analysis of cases with bronchial asthma in the post-COVID-19 period highlights the frequency of respiratory, cardiovascular and neuropsychiatric symptoms, increased inflammatory biochemical markers, dysregulation of pulmonary respiratory function. Elderly patients with asthma in the post-COVID-19 period exhibit some peculiarities, such as high comorbidity, use of a large number of medications, individualized response to treatment, different perception of symptoms and a higher mortality rate. These aspects emphasize the need to maintain optimal asthma control and prevent exacerbations that can accelerate the progression to respiratory failure. Further research is needed to effectively address issues related to different asthma phenotypes, treatment intensity and degree of disease.

1 February 2023 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
VDValeriu Djugostran
Valeriu Djugostran
VAVasile Antipa
Vasile Antipa
SGSvetlana Garaeva
Svetlana Garaeva
GPGalina Postolatii
Galina Postolatii
LCLucia Ceapa-Catana
Lucia Ceapa-Catana
The study is prospective, controlled, monocentric, randomized, descriptive-interventional, which proves the superiority of the treatment of drug – resistant pulmonary tuberculosis patients with thematic methods supplemented by the administration of the hyperosmolar mixture of аmine acids - Aminol and the lymphotropic use of isoniazid solution, compared to the routine medication performed according to the DOTS plus schemes.